Redsense Medical

From Wikitia
Jump to navigation Jump to search
Redsense Medical
IndustryMedical devices
Founded2006; 17 years ago (2006)
Area served
United States, Europe, Sweden
Key people
Patrik Byhmer {CEO)
ProductsRedsense Alarm

Redsense Medical is a Swedish publicly traded medical devices company, established in Halmstad, Sweden, in 2006, that focuses on supervision of hemodialysis treatment to prevent blood loss from venous needle dislodgement. The company's main market is the United States, but it also maintains active operations throughout Europe.[1]


Redsense Medical's main product is the Redsense Alarm. This device is an alarm system for hemodialysis treatment that continuosly monitors a vascular access for blood leakage by optical means.[2] The technology obtained FDA approval in 2007[3] and was used in clinical practice in thirteen countries by 2011.[4]

In 2010, the U.S. federal agency Department of Veterans Affairs, which provides healthcare services to 9 million[5] military veterans through a nation-wide network of clinics, issued a patient safety alert making use of the Redsense Alarm mandatory for patients identified as being at risk of venous needle dislodgement. The decision followed an analysis of previous bleeding episodes in the dialysis facilities operated by the agency, where the dialysis machines in many cases had failed to alarm. The review was based on more than 3.5 million instances of treatment.[6]

In the media



  1. "Så räddar de dialyspatienters liv". January 21, 2020.
  2. Schultz, Charlotta von. "Svenskt dialyslarm ska rädda liv". Ny Teknik.
  3. Schultz, Charlotta von. "Grönt ljus i USA för Redsense från Halmstad". Ny Teknik.
  4. Alpman, Marie. "Redsense Medical". Ny Teknik.
  5. Administration, Veterans Health. "Veterans Health Administration".

External links

This article "Redsense Medical" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.